F3Y-97293-66158
3 vaccinations
8 coded responses
32 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 775 / TX
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Survey response — day 0, dose 1MedDRA: Muscle spasms — Feeling: Good · Site: Pain · Chills, Muscle or body achesFree text: The arm where injection was given is very crampyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site swelling, Pain in extremity — Feeling: Good · Site: Pain, SwellingFree text: Pain in Rt arm. Knot at injection site. Rt arm is crampy feeling. Applied Tens Unit today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 1MedDRA: Injection site nodule — Feeling: Good · Site: Pain, SwellingFree text: Quarter size knot at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
-
2021-02-18
Dose 2 — Pfizer-BioNTech
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-04-01
Survey response — day 42, dose 2MedDRA: Ageusia, Alopecia, Anosmia, Dysgeusia — Feeling: GoodFree text: Hair loss, no sense of smell & taste is off.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
- 2021-08-19
-
2021-09-21
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-05
- 2021-10-12
- 2021-10-19
-
2021-10-26
Survey response — day 35, dose 3MedDRA: Ageusia, Anosmia, Vision blurred, Vitreous floaters — Feeling: GoodFree text: Still no taste or smell Blurred vision & floatersMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Survey response — day 42, dose 3MedDRA: Alopecia, Vision blurred, Vitreous floaters — Feeling: GoodFree text: Hair loss, blurred vision & floatersMedDRA releases: 2024-11 · check-in free text available
-
2021-12-21
Survey response — 3 months, dose 3MedDRA: Decreased appetite, Hypogeusia, Hyposmia, Vision blurred, Vitreous floaters — Feeling: GoodFree text: Blurred vision, eye floaters, continued decreased appatite, decreased taste & smell.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-22
-
2022-09-21
Survey response — 12 months, dose 3MedDRA: Cataract — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cataract formationMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-22
-
2022-09-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-09-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): The arm where injection was given is very crampy
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Pain in Rt arm. Knot at injection site. Rt arm is crampy feeling. Applied Tens Unit today.
Systemic reaction (other): Quarter size knot at injection site
Release 6 — day 42, dose 2
Symptoms: Hair loss, no sense of smell & taste is off.
Release 10 — day 35, dose 3
Symptoms: Still no taste or smell Blurred vision & floaters
Release 10 — day 42, dose 3
Symptoms: Hair loss, blurred vision & floaters
Release 10 — 3 months, dose 3
Symptoms: Blurred vision, eye floaters, continued decreased appatite, decreased taste & smell.
Release 12 — 12 months, dose 3
Symptoms: Cataract formation
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Cataract | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Hypogeusia | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
| SRO | Injection site nodule | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release